However, we found that OXTR cannot effectively distinguish COAD subgroups, including TNM stage (TNM stages I + II versus TNM stages III + IV, AUC = 0.5639, p = 0.0078, Figure 3c), T stage (stages T1 + T2 versus stages T3 + T4, AUC = 0.5930, p = 0.0090, Figure 3d), OS (OS-good versus OS-poor, AUC = 0.5769, p = 0.0058, Figure 3e), and living status (living versus deceased, AUC = 0.5703, p = 0.0474, Figure 3f). This evidence concerns the gene OXTR and colon adenocarcinoma.